Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis frequency in Israel's diverse populations.

Milton Alter1, Esther Kahana, Nelly Zilber

  • 1Lankenau Institute for Medical Research,Wynnewood, PA 19096, USA.

Neurology
|April 12, 2006
PubMed
Summary

Multiple sclerosis (MS) prevalence varies significantly across diverse ethnic groups in Israel. Israeli-born Jews and European/American immigrants show the highest rates, while North African/Asian immigrants and Arab populations exhibit lower frequencies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

European journal of neurology·2026
Same author

Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study.

Scientific reports·2026
Same author

Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments.

International journal of molecular sciences·2026
Same author

Prognostic Value of CSF Total Tau Protein in Patients with Familial and Sporadic Creutzfeldt-Jakob Disease.

Dementia and geriatric cognitive disorders·2026
Same author

Immunotherapy-mediated modulation of the gut microbiota in multiple sclerosis and associations with diet and clinical response-the effect of dimethyl fumarate therapy.

Therapeutic advances in neurological disorders·2025
Same author

Personalized Intervention to Improve Medication Adherence for Persons with Multiple Sclerosis.

Patient preference and adherence·2024

Area of Science:

  • Epidemiology
  • Neurology
  • Population Health

Background:

  • Israel's long history as a site for epidemiological studies.
  • Advantages of Israel for accurate disease frequency determination: small size, accessible healthcare, detailed data, and a National Multiple Sclerosis (MS) Register since 1960.

Purpose of the Study:

  • To calculate and compare age-specific prevalence of Multiple Sclerosis (MS) across various ethnic groups in Israel.
  • Investigate potential differences in MS frequency based on geographic origin and ethnicity.

Main Methods:

  • Age-specific prevalence of MS was calculated for distinct populations: Israeli-born Jews, Jewish immigrants (Europe/America, North Africa/Asia), Israeli-born Arabs (Christian, Moslem), Druze, and Bedouins.
  • Data collected as of June 30, 2000.

Related Experiment Videos

Main Results:

  • Three distinct tiers of MS prevalence were observed.
  • Highest rates: Israeli-born Jews and Jewish immigrants from Europe/America.
  • Intermediate rates: Jewish immigrants from Africa/Asia and Christian Arabs.
  • Lowest rates: Moslem Arabs, Druze, and Bedouins.

Conclusions:

  • Significant differences in Multiple Sclerosis (MS) frequencies exist among diverse ethnic groups residing in the same geographic area.
  • Ethnic background is a key factor influencing MS prevalence in Israel.